
Articles
-
1 week ago |
theaustralian.com.au | Greg Sheridan |Geordie Gray |James Kirby |Ellie Dudley
Perpetual Resources’ soil sampling extends strike of lithium-bearing pegmatite at main Igrejinha prospect in Brazil to >1.4km First-pass sampling identified new anomaly about 2.3km to the southeast within highly prospective corridor Preparations well advanced for maiden drilling of Igrejinha prospect to start in early June Special Report: Soil sampling at Perpetual Resources’ Igrejinha project in Brazil’s famed Lithium Valley in the Minas Gerais state has identified a broad and coherent...
-
1 week ago |
theaustralian.com.au | Greg Sheridan |James Kirby |Geordie Gray |Greg Brown
StockheadStockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Tylah Tully unpacks Titanium Sands (ASX:TSL) latest news after they were awarded one year retention licences for the company's Sri Lankan heavy mineral sands project, allowing the progression to environmental studies. Watch the video to find out the latest. While Titanium Sands is a Stockhead advertiser, it did not sponsor this content.
-
2 weeks ago |
theaustralian.com.au | Geoff Chambers |Sarah Ison |Greg Sheridan |Janet Albrechtsen
AXL reports more high-grade rare earths results at Caldas project in BrazilProject in same neighbourhood as MEI and VMM discoveriesCompany confident of expanding REE footprint in the regionSpecial Report: Axel REE says auger drilling at its Caldas project in Brazil continues to return high grade rare earth elements including high-value neodymium and praseodymium (NdPr), and dysprosium and terbium (DyTb).
-
1 month ago |
theaustralian.com.au | Robert Gottliebsen |Ellie Dudley |John Ferguson |Greg Sheridan
EBR Systems has applied for a Transitional Pass-Through (TPT) reimbursement scheme for its WISE CRT System through the US Centers for Medicare & Medicaid Services (CMS)The application is for outpatients, following on from a recommendation from the CMS that inpatients be eligible for the New Technology Add-On PaymentThe criteria are the same for both schemes, giving EBR high confidence they will be approved.
-
1 month ago |
theaustralian.com.au | Peta Credlin |Liam Mendes |Yoni Bashan |Greg Sheridan
StockheadRegenerative medicine developer Orthocell (ASX:OCC) has appointed the first four US distributors for its flagship nerve repair product Remplir. The appointments follow FDA clearance for Remplir which landed earlier this month, and Orthocell are expecting first sales in the US very soon. Today, the US' nerve repair market is valued at US$1.6 billion. Orthocell will tap this market through distributors in Michigan, Virginia, Colorado and Indiana.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →